Verici Dx plc (VRCI.L) Share Price & News
Bid
--
-
Ask
- High-
- OPEN-
- VOL-
- MKT CAP-M
- LOW-
- CLOSE-
- SHARES IN ISSUE242.54M
Verici Dx plc Company Profile
The Company is an immuno-diagnostics development company, initially focused on the kidney transplantation market. The Company’s kidney transplant assays use advanced next-generation sequencing that may define a personalised, risk-profile of each patient over the course of their transplant journey, as well as may detect injury in advance of currently available clinical tests.